Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China's first artificial intelligence-assisted Category 1 new drug to reach this ...

It feels like there is an amorality attached to losing weight via GLP-1. Sure, you’re getting thinner, but you didn’t work ...

While the 44-year-old country music star says he has no judgment for celebrities who do use medication for weight loss, he ...

Everyday Health’s weight loss calculator can help you estimate your calorie needs for weight loss. Learn more about how many ...

Oprah Winfrey has spent decades being judged for her weight—but she’s done being shaped by it. In a candid new interview with ...

Many are fiddling their body mass index on online pharmacy sites to qualify for medicines, or microdosing to shift a few ...

Weight loss may be just one side effect of GLP-1 drugs. A new study suggests they're also changing how consumers spend on ...

Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...

Shares of Novo Nordisk (NYSE:NVO) climbed about 9%on Tuesday trade after the U.S. Food and Drug Administration cleared an ...

FDA approves oral semaglutide, the first GLP-1 weight-loss pill, offering effective obesity treatment with cardiovascular protection—no injections needed.

Despite the initial optimism, BMO urged caution, emphasizing that the advantage may be short-lived. The firm said Eli Lilly’s oral GLP-1 candidate, orforglipron, is still expected to receive approval ...

Despite the initial optimism, BMO urged caution, emphasizing that the advantage may be short-lived. The firm said Eli Lilly’s ...